Complementary assets, strategic alliances, and the incumbent's advantage: an empirical study of industry and firm effects in the biopharmaceutical industry

Frank T. Rothaermel ()

Research Policy, 2001, vol. 30, issue 8, pages 1235-1251

Date: 2001
View citations in EconPapers

Downloads: (external link)
http://www.sciencedirect.com/science/article/B6V77 ... 26ed944d9b0c5f281540
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:eee:respol:v:30:y:2001:i:8:p:1235-1251

Access Statistics for this article

Research Policy is edited by M. Bell, B. Martin, W.E. Steinmueller, A. Arora, M. Callon, M. Kenney, S. Kuhlmann, Keun Lee and F. Murray

More articles in Research Policy from Elsevier
Series data maintained by Heidi Boesdal ().